Advisory Services Network, LLC Clovis Oncology, Inc. Transaction History

Advisory Services Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$4.06 - $5.8 $1,299 - $1,856	-320 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $1,606 - $2,256	320 New	320 $2,000
Q1 2021 May 24, 2021	SELL	$4.81 - $10.34 $1,539 - $3,308	-320 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $1,542 - $2,470	320 New	320 $2,000
Q2 2020 Aug 10, 2020	SELL	$5.69 - $9.69 $31,864 - $54,264	-5,600 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $34,872 - $101,750	-9,250 Reduced 62.29%	5,600 $36,000
Q4 2019 Feb 04, 2020	BUY	$3.0 - $16.43 $44,550 - $243,985	14,850 New	14,850 $155,000
Q4 2018 Feb 15, 2019	SELL	$11.63 - $32.67 $3,489 - $9,801	-300 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$29.37 - $49.48 $8,811 - $14,843	300 New	300 $9,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.